查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1808595

再生醫學人工智慧市場（按技術、功能、發展階段、產品、應用和最終用戶產業）—2025-2030 年全球預測

Artificial Intelligence in Regenerative Medicine Market by Technology, Functionality, Stage Of Development, Offerings, Application, End-User Industry - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

再生醫學人工智慧市場規模預計2024年將達到2.9423億美元，2025年將達到3.5793億美元，2030年將達到9.7813億美元，複合年成長率為22.16%。

主要市場統計數據
基準年2024年 2.9423億美元
預計2025年 3.5793億美元
預測年份 2030 9.7813億美元
複合年成長率（%） 22.16%

探索人工智慧與再生醫學的交會點，推動以病人為中心的突破性治療

人工智慧正在重新定義再生醫學的邊界，它使細胞和組織工程達到前所未有的精準度，加速探索，並最佳化治療效果。先進的計算建模與生物學研究的融合，正在開啟一個患者專屬解決方案的新時代，在這個時代，數位平台將指導新型支架的設計、預測細胞行為並最佳化遞送機制。本介紹將全面探討演算法驅動的工具如何與實驗室流程結合，以增強再生介入的有效性和安全性。

檢驗模式轉移技術與臨床進展，重新定義再生醫學治療通訊協定

運算能力的迅猛成長和演算法的日益複雜，正在徹底改變再生醫學的格局。過去十年，影像處理的進步使研究人員能夠以微觀精度繪製組織結構圖，視訊分析平台也使得即時捕捉細胞動態事件成為可能。同時，深度學習框架在解讀基因組和蛋白質組資料集方面展現出令人印象深刻的能力，為基因調控和細胞重編程開闢了新的標靶。

評估美國2025年關稅調整對人工智慧主導的再生醫學領域的累積影響

美國將於2025年起實施新關稅，增加了採購硬體組件、先進影像處理設備和專用試劑的複雜性，而這些對於人工智慧主導的再生研究至關重要。進口高解析度顯微鏡和計算加速器的關稅上調導致供應商合約被重新審查，促使許多實驗室重新評估其長期籌資策略，以確保其營運的連續性。

透過再生醫學人工智慧應用中的綜合多維分割框架揭示關鍵見解

全面的細分分析揭示了人工智慧再生醫學市場在多個維度上的深刻洞察。從底層技術的角度來看，電腦視覺（包括影像處理和視訊分析）的進步與機器學習演算法的突破同步。機器學習演算法包括深度學習、強化學習、監督學習和非監督學習，每種演算法都為複雜的生物現象建模貢獻了獨特的能力。語音辨識和文字分析等自然語言處理技術的結合進一步增強了資料整合，而機器人技術則充當了將電腦指令帶入實驗室環境的物理介面。

突顯重點區域叢集的區域動態和成長模式，促進人工智慧在再生醫學研究中的整合

區域分析揭示了技術採用和協作研究生態系統的多樣化模式。在美洲，公共和私營部門對人工智慧基礎設施和再生醫學的強勁投資創造了強勁的創新環境，美國的主要樞紐推動了開創性的臨床研究和產業合作。相反，歐洲、中東和非洲地區呈現出成熟度水準的混合體，西歐成熟的學術叢集與中東和北非新興的卓越中心並存，凸顯了向跨境聯盟和監管協調舉措的轉變。

介紹塑造全球人工智慧再生治療解決方案未來的關鍵創新者和策略合作者

透過將平台創新與策略夥伴關係相結合，領先企業和先鋒新興企業正在探索人工智慧整合再生醫學的新領域。領先的科技公司正在與細胞治療專家合作，共同開發數據驅動的診斷工具，而成熟的生物製藥公司則正在投資機器學習新興企業，以增強標靶發現並簡化生產流程。同時，生物技術創新者正在將其專有演算法授權給學術中心，建構共用智慧財產權的生態系統，以加速共同進步。

為產業主管提供可行的策略藍圖，利用再生醫學領域的人工智慧創新來獲得競爭優勢

尋求利用人工智慧與再生醫學整合的產業領導者必須制定以資料準備、跨職能協作和敏捷監管參與為中心的策略藍圖。首先，他們必須投資可擴展、安全的資料基礎設施，以容納多樣化的生物醫學資料集，並支援進階模型訓練，同時又不影響合規性。此外，他們必須培養由生物工程師、資料科學家、臨床醫生和監管專家組成的多學科團隊，以彌合知識孤島，並加快轉化里程碑的實現。

了解我們強大的研究途徑，將定量分析與定性見解相結合，以確保數據的完整性和深度

調查方法採用嚴格的多階段方法，旨在確保全面覆蓋和資料完整性。研究流程始於結構化的二次研究階段，涵蓋同儕審查出版品、臨床試驗註冊庫、專利資料庫和監管文件。從這些資訊來源獲得的洞見為制定詳細的資料收集框架提供了依據，隨後開展了一次研究，包括與來自學術界、臨床機構和商業公司的關鍵意見領袖、行業資深人士、技術架構師和最終用戶代表進行深入訪談。

綜合主要研究結果，強調人工智慧在全球再生醫學治療方法發展中的變革作用

這項全面的分析綜合報告凸顯了人工智慧在加速探索、最佳化臨床工作流程和拓展再生醫學前沿方面的變革潛力。先進的影像處理和預測分析技術能夠精確表徵細胞動力學，而自適應學習系統則能夠即時最佳化治療通訊協定。軟體創新者與生物技術公司之間的合作正在創建整合平台，以支援從實驗室研究到臨床部署的決策。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章市場動態

  • 用於動態調整再生製造中生物過程程式參數的強化學習框架
  • 基於電腦視覺的自動再生製造中細胞培養過程的即時監控
  • 人工智慧驅動的幹細胞分化途徑預測模型，用於個人化組織再生
  • 使用人工智慧增強影像分析即時監測組織再生
  • 基於深度學習的3D生物列印參數最佳化，用於製造複雜器官支架
  • 機器學習演算法增強生物材料設計，改善支架的生物相容性和功能
  • 將數位雙胞胎平台與人工智慧結合，模擬特定患者的再生治療結果
  • 用於再生醫學研究流程中自動文獻綜述的自然語言處理工具
  • 人工智慧驅動的生物標記發現，用於客製化組織修復中的免疫調節療法
  • 數位雙胞胎模擬預測類器官生長模式和治療結果

第6章 市場洞察

  • 波特五力分析
  • PESTEL分析

第7章 2025年美國關稅的累積影響

第8章再生醫學人工智慧市場（按技術）

  • 電腦視覺
    • 影像處理
    • 影片分析
  • 機器學習演算法
    • 深度學習
    • 強化學習
    • 監督學習
    • 無監督學習
  • 自然語言處理
    • 語音辨識
    • 文字分析
  • 機器人技術

第9章再生醫學人工智慧市場：功能

  • 決策支援系統
  • 預測分析
  • 最佳化您的工作流程

第 10 章再生醫學人工智慧市場（按發展階段）

  • 臨床試驗
  • 臨床前

第 11 章再生醫學人工智慧市場（按類型）

  • 服務
    • 諮詢與實施
    • 維護和支援
  • 軟體
    • 人工智慧演算法和平台
    • 數據分析和視覺化工具

第 12 章再生醫學人工智慧市場（按應用）

  • 心血管疾病
    • 心肌梗塞的治療
    • 血管組織修復
  • 神經病學
    • 神經退化性疾病
    • 修復創傷性腦損傷
  • 腫瘤學
    • 癌症疫苗
    • 基因轉移療法
  • 眼科
    • 角膜修復
    • 視網膜疾病治療
  • 整形外科
    • 骨再生
    • 軟骨修復
    • 脊椎疾病的治療

第 13 章 再生醫學人工智慧市場（按最終用戶產業）

  • 學術研究機構
  • 醫院和診所
  • 製藥和生物技術公司

14. 美國醫療機構人工智慧市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

第 15 章歐洲、中東和非洲再生醫學人工智慧市場

  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 阿拉伯聯合大公國
  • 沙烏地阿拉伯
  • 南非
  • 丹麥
  • 荷蘭
  • 卡達
  • 芬蘭
  • 瑞典
  • 奈及利亞
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波蘭
  • 瑞士

16. 亞太地區再生醫學人工智慧市場

  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • 印尼
  • 泰國
  • 菲律賓
  • 馬來西亞
  • 新加坡
  • 越南
  • 台灣

第17章競爭格局

  • 2024年市場佔有率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Aiforia Technologies Plc
    • Aspen Neuroscience
    • Celularity Inc.
    • Deep Genomics Incorporated
    • Epistra Inc.
    • Exscientia plc
    • F. Hoffmann-La Roche Ltd.
    • Insilico Medicine
    • Intel Corporation
    • Juvenescence Therapeutics Limited
    • Medtronic PLC
    • Merck KGaA
    • Microsoft Corporation
    • Novo Nordisk A/S
    • NVIDIA Corporation
    • Owkin, Inc
    • Pandorum Technologies Pvt. Ltd
    • Recursion Pharmaceuticals
    • Sanofi SA
    • SOMITE THERAPEUTICS.
    • Tempus Labs, Inc.
    • Wipro Limited

第18章 研究人工智慧

第19章 研究統計

第20章 研究聯絡人

第21章 研究報導

第22章 附錄

Product Code: MRR-A6768A62EE02

The Artificial Intelligence in Regenerative Medicine Market was valued at USD 294.23 million in 2024 and is projected to grow to USD 357.93 million in 2025, with a CAGR of 22.16%, reaching USD 978.13 million by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 294.23 million
Estimated Year [2025] USD 357.93 million
Forecast Year [2030] USD 978.13 million
CAGR (%) 22.16%

Unveiling the Intersection of Artificial Intelligence and Regenerative Medicine to Propel Revolutionary Patient-Centric Therapies

Artificial intelligence is redefining the boundaries of regenerative medicine by enabling unprecedented precision in cell and tissue engineering, accelerating discovery, and optimizing therapeutic outcomes. The convergence of advanced computational models with biological research has ushered in a new era of patient-specific solutions, where digital platforms guide the design of novel scaffolds, predict cell behavior, and refine delivery mechanisms. This introduction sets the stage for a comprehensive exploration of how algorithm-driven tools integrate with laboratory processes to amplify the efficacy and safety of regenerative interventions.

By harnessing sophisticated pattern recognition capabilities, researchers are now able to decode complex cellular interactions in ways that were previously unattainable. Visual computing systems transform microscopic imagery into actionable data, while adaptive learning algorithms continuously refine predictions based on new experimental results. Furthermore, robotics-mediated automation streamlines labor-intensive workflows, freeing scientific teams to focus on strategic innovation rather than repetitive tasks.

As this report unfolds, you will discover how these synergistic technologies coalesce to build a robust infrastructure for regenerative medicine. From initial proof-of-concept studies through late-stage clinical evaluations, the integration of AI lays a foundation for scalable manufacturing, regulatory compliance, and personalized treatment modalities that hold the promise of transforming patient care on a global scale.

Examining the Paradigm-Shifting Technological and Clinical Advances That Are Redefining Treatment Protocols in Regenerative Medicine

The landscape of regenerative medicine has undergone transformative shifts driven by breakthroughs in computational power and algorithmic sophistication. Over the past decade, image processing innovations have enabled researchers to map tissue architectures with microscopic accuracy, while video analysis platforms have captured dynamic cellular events in real time. Simultaneously, deep learning frameworks have demonstrated remarkable proficiency in deciphering genomic and proteomic datasets, unlocking new targets for gene modulation and cellular reprogramming.

Natural language processing has revolutionized literature mining, facilitating rapid synthesis of research findings and enabling automated hypothesis generation from vast repositories of scientific publications. Voice-enabled interfaces now support hands-free laboratory control, enhancing efficiency in sterile environments. On the manufacturing front, robotics integration has matured, offering high-throughput bioprinting capabilities that produce consistent tissue constructs at scale.

These technological advancements have not only accelerated R&D timelines but have also redefined collaboration paradigms. Multidisciplinary teams now leverage decision support systems that merge predictive analytics with domain expertise. Workflow optimization engines dynamically allocate resources, reducing bottlenecks and improving reproducibility. As regulatory agencies increasingly recognize the crucial role of these tools, adaptive approval pathways are emerging, setting the stage for wider clinical adoption of AI-enabled regenerative therapies.

Assessing the Cumulative Consequences of United States 2025 Tariff Adjustments on the Artificial Intelligence-Driven Regenerative Medicine Sector

The implementation of new tariff measures in the United States from 2025 onward has introduced additional layers of complexity to the procurement of critical hardware components, advanced imaging devices, and specialized reagents pivotal to AI-driven regenerative research. Elevated duties on imported high-resolution microscopes and computing accelerators have led to recalibrated vendor contracts, prompting many laboratories to reevaluate long-term procurement strategies in an effort to safeguard operational continuity.

Over time, stakeholders have witnessed a cumulative impact that extends beyond immediate cost escalations. Collaborative projects between academic research centers and global technology providers have encountered negotiation delays as pricing structures are adjusted. Some organizations have responded by increasing domestic sourcing or by forging alliances with local manufacturers capable of delivering compliant instrumentation at competitive rates. However, these shifts have also constrained access to niche components that remain scarce in domestic markets.

In parallel, startups in the AI-regenerative medicine nexus are reassessing capital allocation toward infrastructure investments, mindful of the risk associated with fluctuating international trade policies. As a consequence, many venture-backed enterprises are accelerating efforts to develop in-house capabilities for data annotation, algorithmic training, and prototype fabrication, reducing reliance on imported modules. Looking ahead, industry leaders must navigate this evolving tariff environment by cultivating diversified supplier networks and leveraging policy advocacy to mitigate supply chain vulnerabilities.

Uncovering Critical Insights Through a Comprehensive Multi-Dimensional Segmentation Framework in Regenerative Medicine AI Applications

A thorough segmentation analysis reveals nuanced insights across multiple dimensions of the AI-enabled regenerative medicine market. When viewed through the lens of underlying technology, it becomes evident that advances in computer vision, which encompass both image processing and video analysis, have been paralleled by breakthroughs in machine learning algorithms. The latter category comprises deep learning, reinforcement learning, supervised learning, and unsupervised learning, each contributing distinct capabilities to model complex biological phenomena. Incorporation of natural language processing techniques such as speech recognition and text analysis further enhances data integration, while robotics serves as the physical interface that brings computational directives into the laboratory setting.

Evaluating functionality demonstrates that decision support systems, predictive analysis modules, and workflow optimization tools are increasingly indispensable for research and clinical operations. These platforms streamline critical decision pathways, offering dynamic recommendations that reduce trial-and-error cycles. Across stages of development, ongoing preclinical investigations feed data-driven hypotheses into clinical trials, establishing a feedback loop that accelerates translational progress.

Insights into product offerings indicate that service-based solutions-ranging from consulting and implementation to maintenance and support-are complemented by software packages built on AI algorithms, platforms, and data analytics and visualization tools. This duality ensures clients receive end-to-end support, from initial deployment through iterative enhancements. Finally, practical applications span major therapeutic areas including cardiovascular diseases with a focus on myocardial infarction therapy and vascular tissue repair, neurology targeting neurodegenerative disorders and traumatic brain injury repair, oncology through cancer vaccines and gene transduction therapies, ophthalmology addressing corneal repair and retinal disease therapy, and orthopedics encompassing bone regeneration, cartilage repair, and spinal disorder treatments. End-user industries for these solutions include academic and research institutes, hospitals and clinics, and pharmaceutical and biotechnology companies, each leveraging AI-driven insights to advance their unique missions.

Highlighting Regional Dynamics and Growth Patterns Across Key Territory Clusters Driving AI Integration in Regenerative Medicine Research

Regional analysis uncovers diverse patterns of technology adoption and collaborative research ecosystems. In the Americas, strong public and private investment in both AI infrastructure and regenerative medicine has created a robust innovation climate, with major hubs in the United States driving trailblazing clinical studies and industrial partnerships. Conversely, European, Middle Eastern, and African regions exhibit a mosaic of maturity levels, where established academic clusters in Western Europe coexist with emerging centers of excellence in the Middle East and North Africa, underscoring a shift toward cross-border consortia and regulatory harmonization initiatives.

Meanwhile, Asia-Pacific markets demonstrate rapid expansion fueled by government-sponsored research programs and growing biomanufacturing capacities. Nations in East Asia are advancing high-throughput bioprinting and cell therapy platforms, while Southeast Asian countries are leveraging cost-effective clinical trial sites to attract international collaborations. Taken together, these regional dynamics highlight a global convergence toward shared best practices, multi-stakeholder funding models, and harmonized data governance frameworks that accelerate the translation of AI-powered regenerative therapies from lab to clinic.

As research networks strengthen their cross-continental ties, manufacturers and technology providers are aligning distribution strategies and forging licensing agreements to ensure timely delivery of critical components. These synergistic efforts underscore the importance of regional insight when charting strategic market entry and expansion plans.

Profiling the Leading Innovators and Strategic Collaborators Shaping the Future of AI-Enabled Regenerative Therapeutic Solutions Globally

Leading corporations and pioneering startups are forging a new frontier in AI-integrated regenerative medicine by combining platform innovations with strategic partnerships. Major technology firms are collaborating with cell therapy specialists to co-develop data-driven diagnostic tools, while established biopharmaceutical companies invest in machine learning startups to bolster target discovery and streamline manufacturing pipelines. At the same time, biotech innovators are licensing proprietary algorithms to academic centers, creating an ecosystem where shared intellectual assets accelerate collective progress.

These strategic collaborations extend into multi-institutional alliances that integrate complementary strengths: computational design houses contributing algorithmic expertise connect with contract development organizations offering bioprocessing capabilities, forging end-to-end value chains. Moreover, recent mergers and acquisitions have reshaped the competitive landscape, enabling some players to vertically integrate AI analytics, cloud infrastructure, and cell culture facilities under a single organizational umbrella. This consolidation trend is complemented by consortium-based initiatives that democratize access to high-performance computing and standardized datasets, mitigating barriers for emerging entrants.

As capital continues to flow into this intersection of AI and regenerative medicine, corporate strategies are evolving to emphasize ecosystem development over product-centric approaches. By nurturing collaborative networks, these companies are not only accelerating innovation cycles but also establishing robust intellectual property portfolios that set the stage for long-term market leadership.

Actionable Strategic Roadmap for Industry Executives to Harness AI Innovations in Regenerative Medicine for Competitive Advantage

Industry leaders seeking to capitalize on the convergence of artificial intelligence and regenerative medicine must adopt a strategic roadmap centered on data readiness, cross-functional collaboration, and agile regulatory engagement. First, they should invest in scalable, secure data infrastructure that accommodates diverse biomedical datasets and supports advanced model training without compromising compliance. Coupled with this, organizations need to cultivate cross-disciplinary teams comprising bioengineers, data scientists, clinicians, and regulatory experts to bridge knowledge silos and expedite translational milestones.

Concurrently, proactive engagement with regulatory bodies can shape adaptive oversight frameworks that foster innovation while ensuring patient safety. Companies are advised to participate in pilot programs and public-private partnerships that co-create guidelines for AI-driven medical devices and biologics. By doing so, stakeholders can influence standards, gain early feedback, and reduce time-to-market for novel therapies.

Finally, forging ecosystem partnerships-whether through consortium memberships, joint ventures, or licensing agreements-will be crucial to access complementary capabilities. Aligning with academic institutions or technology providers can unlock specialized expertise, shared infrastructure, and co-investment opportunities. Through these deliberate actions, executives will position their organizations to harness AI innovations effectively, drive competitive differentiation, and ultimately deliver transformative therapeutic solutions to patients.

Detailing a Robust Research Approach Integrating Quantitative Analyses and Qualitative Insights to Ensure Data Integrity and Depth

This research integrates a rigorous multi-phased methodology designed to ensure comprehensive coverage and data integrity. The process commenced with a structured secondary research phase, encompassing peer-reviewed publications, clinical trial registries, patent databases, and regulatory filings. Insights gleaned from these sources informed the development of a detailed data collection framework, followed by primary research comprising in-depth interviews with key opinion leaders, industry veterans, technology architects, and end-user representatives across academia, clinical settings, and commercial enterprises.

Quantitative analyses were conducted using advanced statistical techniques and machine learning-based data modeling, enabling robust identification of correlations, trend extrapolations, and scenario simulations. Qualitative evaluation complemented these findings through thematic coding of interview transcripts and case study analyses, illuminating contextual factors and strategic considerations that numbers alone cannot capture. Triangulation across secondary sources, primary insights, and analytical models further validated results and illuminated areas of convergence or discrepancy.

Throughout the process, stringent quality control measures-such as peer reviews, audit trails, and consistency checks-ensured the credibility and reproducibility of the findings. This integrated research design provides stakeholders with a transparent, evidence-based foundation for informed decision-making within the rapidly evolving intersection of AI and regenerative medicine.

Synthesizing Key Findings to Illuminate the Transformational Role of AI in Advancing Regenerative Medicine Therapeutic Modalities Globally

The synthesis of this comprehensive analysis underscores the transformational potential of artificial intelligence to accelerate discovery, optimize clinical workflows, and expand the frontiers of regenerative medicine. Advanced image processing and predictive analytics are enabling precise characterization of cellular dynamics, while adaptive learning systems refine therapeutic protocols in real time. Collaboration between software innovators and biotech organizations is yielding integrated platforms that support decision-making from laboratory research through clinical deployment.

Regional and tariff considerations further highlight the necessity for flexible sourcing strategies and policy engagement to sustain innovation momentum. Segmentation insights reveal that success hinges on tailored offerings that address distinct technological, functional, and developmental requirements, as well as specific therapeutic applications ranging from cardiovascular repair to neurologic and oncologic interventions. Strategic alliances and ecosystem-based approaches emerge as critical enablers, fostering shared infrastructure, co-investment, and regulatory alignment.

In conclusion, the intersection of AI and regenerative medicine represents a paradigm shift with far-reaching implications for healthcare. By embracing data-driven methodologies, fostering multidisciplinary partnerships, and navigating evolving trade environments, stakeholders can unlock unprecedented opportunities to deliver personalized, effective, and scalable therapies that improve patient outcomes globally.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Reinforcement learning frameworks to dynamically adjust bioprocess parameters in regenerative manufacturing
  • 5.2. Computer vision-based real-time monitoring of cell culture processes in automated regenerative manufacturing
  • 5.3. AI-driven predictive modeling of stem cell differentiation pathways for personalized tissue regeneration
  • 5.4. Real-time monitoring of tissue regeneration using AI-enhanced imaging analytics
  • 5.5. Deep learning-powered optimization of 3D bioprinting parameters for complex organ scaffold fabrication
  • 5.6. Machine learning algorithms enhancing biomaterials design for improved scaffold biocompatibility and function
  • 5.7. Integration of digital twin platforms with AI to simulate patient-specific regenerative therapy outcomes
  • 5.8. Natural language processing tools for automated literature review in regenerative medicine research pipelines
  • 5.9. AI powered biomarker discovery for customizing immunomodulatory treatments in tissue repair
  • 5.10. Digital twin simulations for predicting organoid growth patterns and therapeutic efficacy outcomes

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Artificial Intelligence in Regenerative Medicine Market, by Technology

  • 8.1. Introduction
  • 8.2. Computer Vision
    • 8.2.1. Image Processing
    • 8.2.2. Video Analysis
  • 8.3. Machine Learning Algorithms
    • 8.3.1. Deep Learning
    • 8.3.2. Reinforcement Learning
    • 8.3.3. Supervised Learning
    • 8.3.4. Unsupervised Learning
  • 8.4. Natural Language Processing
    • 8.4.1. Speech Recognition
    • 8.4.2. Text Analysis
  • 8.5. Robotics

9. Artificial Intelligence in Regenerative Medicine Market, by Functionality

  • 9.1. Introduction
  • 9.2. Decision Support Systems
  • 9.3. Predictive Analysis
  • 9.4. Workflow Optimization

10. Artificial Intelligence in Regenerative Medicine Market, by Stage Of Development

  • 10.1. Introduction
  • 10.2. Clinical Trials
  • 10.3. Preclinical

11. Artificial Intelligence in Regenerative Medicine Market, by Offerings

  • 11.1. Introduction
  • 11.2. Service
    • 11.2.1. Consulting & Implementation
    • 11.2.2. Maintenance & Support
  • 11.3. Software
    • 11.3.1. AI Algorithms & Platforms
    • 11.3.2. Data Analytics & Visualization Tools

12. Artificial Intelligence in Regenerative Medicine Market, by Application

  • 12.1. Introduction
  • 12.2. Cardiovascular Diseases
    • 12.2.1. Myocardial Infarction Therapy
    • 12.2.2. Vascular Tissue Repair
  • 12.3. Neurology
    • 12.3.1. Neurodegenerative Disorders
    • 12.3.2. Traumatic Brain Injury Repair
  • 12.4. Oncology
    • 12.4.1. Cancer Vaccine
    • 12.4.2. Gene Transduction Therapy
  • 12.5. Ophthalmology
    • 12.5.1. Corneal Repair
    • 12.5.2. Retinal Disease Therapy
  • 12.6. Orthopedics
    • 12.6.1. Bone Regeneration
    • 12.6.2. Cartilage Repair
    • 12.6.3. Spinal Disorders Treatment

13. Artificial Intelligence in Regenerative Medicine Market, by End-User Industry

  • 13.1. Introduction
  • 13.2. Academic & Research Institutes
  • 13.3. Hospitals And Clinics
  • 13.4. Pharmaceutical & Biotechnology Companies

14. Americas Artificial Intelligence in Regenerative Medicine Market

  • 14.1. Introduction
  • 14.2. United States
  • 14.3. Canada
  • 14.4. Mexico
  • 14.5. Brazil
  • 14.6. Argentina

15. Europe, Middle East & Africa Artificial Intelligence in Regenerative Medicine Market

  • 15.1. Introduction
  • 15.2. United Kingdom
  • 15.3. Germany
  • 15.4. France
  • 15.5. Russia
  • 15.6. Italy
  • 15.7. Spain
  • 15.8. United Arab Emirates
  • 15.9. Saudi Arabia
  • 15.10. South Africa
  • 15.11. Denmark
  • 15.12. Netherlands
  • 15.13. Qatar
  • 15.14. Finland
  • 15.15. Sweden
  • 15.16. Nigeria
  • 15.17. Egypt
  • 15.18. Turkey
  • 15.19. Israel
  • 15.20. Norway
  • 15.21. Poland
  • 15.22. Switzerland

16. Asia-Pacific Artificial Intelligence in Regenerative Medicine Market

  • 16.1. Introduction
  • 16.2. China
  • 16.3. India
  • 16.4. Japan
  • 16.5. Australia
  • 16.6. South Korea
  • 16.7. Indonesia
  • 16.8. Thailand
  • 16.9. Philippines
  • 16.10. Malaysia
  • 16.11. Singapore
  • 16.12. Vietnam
  • 16.13. Taiwan

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Aiforia Technologies Plc
    • 17.3.2. Aspen Neuroscience
    • 17.3.3. Celularity Inc.
    • 17.3.4. Deep Genomics Incorporated
    • 17.3.5. Epistra Inc.
    • 17.3.6. Exscientia plc
    • 17.3.7. F. Hoffmann-La Roche Ltd.
    • 17.3.8. Insilico Medicine
    • 17.3.9. Intel Corporation
    • 17.3.10. Juvenescence Therapeutics Limited
    • 17.3.11. Medtronic PLC
    • 17.3.12. Merck KGaA
    • 17.3.13. Microsoft Corporation
    • 17.3.14. Novo Nordisk A/S
    • 17.3.15. NVIDIA Corporation
    • 17.3.16. Owkin, Inc
    • 17.3.17. Pandorum Technologies Pvt. Ltd
    • 17.3.18. Recursion Pharmaceuticals
    • 17.3.19. Sanofi SA
    • 17.3.20. SOMITE THERAPEUTICS.
    • 17.3.21. Tempus Labs, Inc.
    • 17.3.22. Wipro Limited

18. ResearchAI

19. ResearchStatistics

20. ResearchContacts

21. ResearchArticles

22. Appendix

LIST OF FIGURES

  • FIGURE 1. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY FUNCTIONALITY, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY FUNCTIONALITY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STAGE OF DEVELOPMENT, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STAGE OF DEVELOPMENT, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERINGS, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERINGS, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER INDUSTRY, 2024 VS 2030 (%)
  • FIGURE 16. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER INDUSTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 18. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 20. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 23. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 24. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 25. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 26. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 27. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET: RESEARCHAI
  • FIGURE 28. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET: RESEARCHSTATISTICS
  • FIGURE 29. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET: RESEARCHCONTACTS
  • FIGURE 30. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COMPUTER VISION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COMPUTER VISION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY IMAGE PROCESSING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY IMAGE PROCESSING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY VIDEO ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY VIDEO ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COMPUTER VISION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COMPUTER VISION, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MACHINE LEARNING ALGORITHMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MACHINE LEARNING ALGORITHMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY DEEP LEARNING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY DEEP LEARNING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY REINFORCEMENT LEARNING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY REINFORCEMENT LEARNING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SUPERVISED LEARNING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SUPERVISED LEARNING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY UNSUPERVISED LEARNING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY UNSUPERVISED LEARNING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MACHINE LEARNING ALGORITHMS, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MACHINE LEARNING ALGORITHMS, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SPEECH RECOGNITION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SPEECH RECOGNITION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TEXT ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TEXT ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ROBOTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ROBOTICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY DECISION SUPPORT SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY DECISION SUPPORT SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY PREDICTIVE ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY PREDICTIVE ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY WORKFLOW OPTIMIZATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY WORKFLOW OPTIMIZATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STAGE OF DEVELOPMENT, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STAGE OF DEVELOPMENT, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY PRECLINICAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY PRECLINICAL, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SERVICE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SERVICE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CONSULTING & IMPLEMENTATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CONSULTING & IMPLEMENTATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 61. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MAINTENANCE & SUPPORT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MAINTENANCE & SUPPORT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 63. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SERVICE, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SERVICE, 2025-2030 (USD MILLION)
  • TABLE 65. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 67. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY AI ALGORITHMS & PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY AI ALGORITHMS & PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 69. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY DATA ANALYTICS & VISUALIZATION TOOLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY DATA ANALYTICS & VISUALIZATION TOOLS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 71. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 73. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 75. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 77. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MYOCARDIAL INFARCTION THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MYOCARDIAL INFARCTION THERAPY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 79. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY VASCULAR TISSUE REPAIR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY VASCULAR TISSUE REPAIR, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 81. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2025-2030 (USD MILLION)
  • TABLE 83. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 85. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 87. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TRAUMATIC BRAIN INJURY REPAIR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TRAUMATIC BRAIN INJURY REPAIR, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 89. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
  • TABLE 91. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 93. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CANCER VACCINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CANCER VACCINE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 95. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY GENE TRANSDUCTION THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY GENE TRANSDUCTION THERAPY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 97. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
  • TABLE 99. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 101. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CORNEAL REPAIR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CORNEAL REPAIR, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 103. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY RETINAL DISEASE THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY RETINAL DISEASE THERAPY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 105. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
  • TABLE 107. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 109. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY BONE REGENERATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY BONE REGENERATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 111. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CARTILAGE REPAIR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CARTILAGE REPAIR, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 113. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SPINAL DISORDERS TREATMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SPINAL DISORDERS TREATMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 115. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ORTHOPEDICS, 2025-2030 (USD MILLION)
  • TABLE 117. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER INDUSTRY, 2025-2030 (USD MILLION)
  • TABLE 119. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 121. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 123. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 125. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 126. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 127. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COMPUTER VISION, 2018-2024 (USD MILLION)
  • TABLE 128. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COMPUTER VISION, 2025-2030 (USD MILLION)
  • TABLE 129. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MACHINE LEARNING ALGORITHMS, 2018-2024 (USD MILLION)
  • TABLE 130. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MACHINE LEARNING ALGORITHMS, 2025-2030 (USD MILLION)
  • TABLE 131. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 132. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2025-2030 (USD MILLION)
  • TABLE 133. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
  • TABLE 134. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
  • TABLE 135. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STAGE OF DEVELOPMENT, 2018-2024 (USD MILLION)
  • TABLE 136. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STAGE OF DEVELOPMENT, 2025-2030 (USD MILLION)
  • TABLE 137. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 138. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
  • TABLE 139. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SERVICE, 2018-2024 (USD MILLION)
  • TABLE 140. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SERVICE, 2025-2030 (USD MILLION)
  • TABLE 141. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 142. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 143. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 144. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 145. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2024 (USD MILLION)
  • TABLE 146. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2025-2030 (USD MILLION)
  • TABLE 147. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
  • TABLE 148. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
  • TABLE 149. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 150. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
  • TABLE 151. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
  • TABLE 152. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
  • TABLE 153. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
  • TABLE 154. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ORTHOPEDICS, 2025-2030 (USD MILLION)
  • TABLE 155. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 156. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER INDUSTRY, 2025-2030 (USD MILLION)
  • TABLE 157. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 159. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 160. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 161. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COMPUTER VISION, 2018-2024 (USD MILLION)
  • TABLE 162. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COMPUTER VISION, 2025-2030 (USD MILLION)
  • TABLE 163. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MACHINE LEARNING ALGORITHMS, 2018-2024 (USD MILLION)
  • TABLE 164. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MACHINE LEARNING ALGORITHMS, 2025-2030 (USD MILLION)
  • TABLE 165. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 166. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2025-2030 (USD MILLION)
  • TABLE 167. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
  • TABLE 168. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
  • TABLE 169. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STAGE OF DEVELOPMENT, 2018-2024 (USD MILLION)
  • TABLE 170. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STAGE OF DEVELOPMENT, 2025-2030 (USD MILLION)
  • TABLE 171. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 172. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
  • TABLE 173. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SERVICE, 2018-2024 (USD MILLION)
  • TABLE 174. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SERVICE, 2025-2030 (USD MILLION)
  • TABLE 175. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 176. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 177. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 178. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 179. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2024 (USD MILLION)
  • TABLE 180. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2025-2030 (USD MILLION)
  • TABLE 181. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
  • TABLE 182. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
  • TABLE 183. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 184. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
  • TABLE 185. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
  • TABLE 186. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
  • TABLE 187. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
  • TABLE 188. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ORTHOPEDICS, 2025-2030 (USD MILLION)
  • TABLE 189. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 190. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER INDUSTRY, 2025-2030 (USD MILLION)
  • TABLE 191. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 192. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 193. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 194. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 195. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COMPUTER VISION, 2018-2024 (USD MILLION)
  • TABLE 196. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COMPUTER VISION, 2025-2030 (USD MILLION)
  • TABLE 197. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MACHINE LEARNING ALGORITHMS, 2018-2024 (USD MILLION)
  • TABLE 198. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MACHINE LEARNING ALGORITHMS, 2025-2030 (USD MILLION)
  • TABLE 199. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 200. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2025-2030 (USD MILLION)
  • TABLE 201. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
  • TABLE 202. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
  • TABLE 203. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STAGE OF DEVELOPMENT, 2018-2024 (USD MILLION)
  • TABLE 204. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STAGE OF DEVELOPMENT, 2025-2030 (USD MILLION)
  • TABLE 205. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 206. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
  • TABLE 207. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SERVICE, 2018-2024 (USD MILLION)
  • TABLE 208. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SERVICE, 2025-2030 (USD MILLION)
  • TABLE 209. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 210. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 211. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 212. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 213. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2024 (USD MILLION)
  • TABLE 214. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2025-2030 (USD MILLION)
  • TABLE 215. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
  • TABLE 216. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
  • TABLE 217. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 218. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
  • TABLE 219. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
  • TABLE 220. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
  • TABLE 221. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
  • TABLE 222. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ORTHOPEDICS, 2025-2030 (USD MILLION)
  • TABLE 223. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 224. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER INDUSTRY, 2025-2030 (USD MILLION)
  • TABLE 225. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 226. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 227. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COMPUTER VISION, 2018-2024 (USD MILLION)
  • TABLE 228. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COMPUTER VISION, 2025-2030 (USD MILLION)
  • TABLE 229. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MACHINE LEARNING ALGORITHMS, 2018-2024 (USD MILLION)
  • TABLE 230. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MACHINE LEARNING ALGORITHMS, 2025-2030 (USD MILLION)
  • TABLE 231. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 232. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2025-2030 (USD MILLION)
  • TABLE 233. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
  • TABLE 234. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
  • TABLE 235. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STAGE OF DEVELOPMENT, 2018-2024 (USD MILLION)
  • TABLE 236. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STAGE OF DEVELOPMENT, 2025-2030 (USD MILLION)
  • TABLE 237. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 238. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
  • TABLE 239. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SERVICE, 2018-2024 (USD MILLION)
  • TABLE 240. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SERVICE, 2025-2030 (USD MILLION)
  • TABLE 241. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 242. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 243. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 244. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 245. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2024 (USD MILLION)
  • TABLE 246. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2025-2030 (USD MILLION)
  • TABLE 247. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
  • TABLE 248. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
  • TABLE 249. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 250. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
  • TABLE 251. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
  • TABLE 252. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
  • TABLE 253. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
  • TABLE 254. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ORTHOPEDICS, 2025-2030 (USD MILLION)
  • TABLE 255. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER I